NCT05222152View on ClinicalTrials.gov

Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

November 23, 2021

Primary Completion Date

October 18, 2023

Study Completion Date

October 18, 2023

Conditions
Primary Adrenal Insufficiency
Interventions
DRUG

Chronocort

Hydrocortisone modified-release hard gelatin capsules for oral administration - 5mg and 10mg

DRUG

Plenadren

Hydrocortisone modified-release tablets for oral administration - 5mg and 20mg

Trial Locations (8)

20095

Diurnal Investigational Site in Hamburg, Hamburg

80336

Diurnal Investigational Site in Munich, Munich

81667

Diurnal Investigational Site in Munich, Munich

97080

Diurnal Investigational Site in Würzburg, Würzburg

B15 2TT

Diurnal Investigational Site in Birmingham, Birmingham

CF14 4XW

Diurnal Investigational Site in Cardiff, Cardiff

NE1 4LP

Diurnal Investigational Site in Newcastle, Newcastle

S10 2JF

Diurnal Investigational Site in Sheffield, Sheffield

All Listed Sponsors
lead

Neurocrine UK Limited

INDUSTRY

NCT05222152 - Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency | Biotech Hunter | Biotech Hunter